B-SOFT Co.,Ltd. (SHE:300451)
China · Delayed Price · Currency is CNY 3.600
+0.030 (0.84%)
Aug 3, 2026, 3:04 PM CST
B-SOFT Market Cap
B-SOFT has a market cap or net worth of 5.53 billion as of August 3, 2026. Its market cap has decreased by -39.82% in one year.
Market Cap
5.53B
Enterprise Value
5.39B
Revenue
958.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.60
ChartMarket Cap Chart
Since May 14, 2015, B-SOFT's market cap has increased from 1.37B to 5.53B, an increase of 302.82%. That is a compound annual growth rate of 13.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 5.53B | -26.02% |
| Dec 31, 2025 | 7.48B | 8.04% |
| Dec 31, 2024 | 6.92B | -31.60% |
| Dec 29, 2023 | 10.12B | -17.04% |
| Dec 30, 2022 | 12.19B | -29.16% |
| Dec 31, 2021 | 17.21B | 7.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi AppTec | 381.95B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 356.72B |
| Shenzhen Mindray Bio-Medical Electronics | 192.15B |
| Sichuan Biokin Pharmaceutical | 123.04B |
| Jinghua Pharmaceutical Group | 5.59B |
| Hangzhou Biotest Biotech | 5.59B |
| Hubei Huaqiang High-Tech | 5.52B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 5.52B |